Press release
Breast Cancer Liquid Biopsy Market Report Examines Leading Companies And Growth Opportunities
Breast Cancer Liquid Biopsy Market
Projected Market Size and Growth Trends for Breast Cancer Liquid Biopsy
The breast cancer liquid biopsy market is forecasted to experience rapid growth, reaching a valuation of $1.75 billion by 2030. This corresponds to a compound annual growth rate (CAGR) of 14.3% over the forecast period. The surge in market size is fueled by factors such as the rising adoption of precision oncology, advancements in AI-powered mutation analysis, personalized treatment planning, expanded use of circulating free DNA (cfDNA) testing, and the decentralization of cancer diagnostics. Key trends influencing this growth include the development of multi-biomarker blood tests, non-invasive methods for cancer monitoring, real-time tracking of treatment responses, early detection of recurrence, and tailored oncology diagnostics.
Download a free sample of the breast cancer liquid biopsy market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21119&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Leading Organizations Driving the Breast Cancer Liquid Biopsy Market
Several prominent companies dominate the breast cancer liquid biopsy landscape. Noteworthy players include Johnson & Johnson Private Limited, Roche Diagnostics, Merck KGaA, Thermo Fisher Scientific, Siemens Healthineers, Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Qiagen N.V., Myriad Genetics Inc., NeoGenomics Laboratories, Guardant Health Inc., Twist Bioscience, Foundation Medicine Inc., Biodesix Inc., Menarini Silicon Biosystems, Datar Cancer Genetics, Abcam plc, OncoDNA SA, Genomic Health Inc., RainDance Technologies, Biocept Inc., Fluxion Biosciences Inc., and Angle plc.
In a significant collaboration announced in January 2024, Guardant Health Inc., a US biotechnology firm focused on liquid biopsies for cancer, partnered with UK-based Hikma Pharmaceuticals plc. This alliance aims to enhance early cancer detection, recurrence monitoring, and optimized treatment selection using Guardant's innovative liquid and tissue biopsy technologies. The partnership is expected to strengthen Guardant Health's reach, particularly addressing cancer challenges within the Middle East and North Africa markets.
View the full breast cancer liquid biopsy market report:
https://www.thebusinessresearchcompany.com/report/breast-cancer-liquid-biopsy-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Emerging Trends Shaping the Breast Cancer Liquid Biopsy Market
Top companies in this space are concentrating on developing companion diagnostic products that support personalized treatment strategies by identifying patients likely to benefit from particular therapies. Companion diagnostics leverage liquid biopsy technology to detect key biomarkers such as genetic mutations, circulating tumor DNA (ctDNA), and protein expressions linked to treatment outcomes.
For example, in January 2023, Guardant Health received FDA approval for its Guardant360 CDx liquid biopsy test as a companion diagnostic for Menarini Group's ORSERDU (elacestrant), a drug for advanced or metastatic breast cancer patients with ESR1 mutations. This approval allows physicians to use the test for comprehensive genomic profiling, helping to select patients suitable for targeted therapies. It marks Guardant Health's first FDA authorization in the breast cancer field and enhances its role in precision oncology.
Segment Insights and Comparative Breakdown within the Breast Cancer Liquid Biopsy Market
This report segments the breast cancer liquid biopsy market across several categories:
1) By Product: Consumables and Kits
2) By Biomarkers: Extracellular Vesicles (EVs), Cell-free DNA (cfDNA), Circulating Tumor RNA (ctRNA), Circulating Tumor Cells (CTCs), Cell-free RNA (cfRNA), and Other Biomarkers
3) By Application: Early Detection or Screening, Diagnosis, and Other Applications
4) By End Users: Laboratories, Hospitals, Physician Laboratories, Reference Laboratories, Public Health Laboratories, Research Institutes, Small Molecular Laboratories, Pathology Laboratories
Further subcategories include:
- Consumables such as Reagents, Polymerase Chain Reaction (PCR) Assays, Sequencing Panels, and Sample Collection Tubes
- Kits covering DNA-based Liquid Biopsy Kits, RNA-based Liquid Biopsy Kits, and Multi-marker Liquid Biopsy Kits
Together, these segments reflect the diverse technologies and approaches shaping the breast cancer liquid biopsy market landscape.
The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Breast Cancer Liquid Biopsy Market Report Examines Leading Companies And Growth Opportunities here
News-ID: 4569388 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for Liquid
Vitamins: The Liquid Goldmine in the Booming Liquid Dietary Supplements Market
The liquid dietary supplements market is experiencing a surge in popularity, driven by consumers seeking convenient and effective ways to boost their health and wellness. Among the diverse offerings, the vitamins segment stands out as a high-opportunity area, catering to a wide range of health needs and preferences.
Market Dynamics and Growth Drivers
Liquid vitamins offer a compelling alternative to traditional pills and capsules, providing faster absorption, easier consumption, and customizable dosages.…
Thermoelectric Assemblies Market, By Type (Air to Air, Direct to Air, Liquid to …
The thermoelectric assemblies market is expected to witness market growth at a rate of 8.25% in the forecast period of 2021 to 2028. Data Bridge Market Research report on thermoelectric assemblies market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The rise in the application of thermoelectric assemblies in the food and beverage industry…
Southeast Asia Liquid Gases Market : Growing with a CAGR of 7.1%, By Type (Liqui …
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged products…
Southeast Asia Liquid Gases Market growing with a CAGR of 7.1%, By Type (Liquid …
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged products…
Southeast Asia liquid gases market growing with a CAGR of 7.1%, Size, Share, Tre …
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged products…
Dual Chamber Prefilled Syringes Market 2021 by Product (Liquid/Powder, Liquid/Li …
The Dual Chamber Prefilled Syringes Market report examines the market size by vital countries/regions, product type, application, historical data, and estimate to forecast. It helps to understand the structure of the Dual Chamber Prefilled Syringes Market by recognizing its different sub-segments. Furthermore, the report focuses on key market players to determine, describe and analyze the value, market share, market competition landscape, SWOT analysis, and development plans in the next few…
